TSC2 and neoplasm: TSC is primarily caused by pathogenic variations in the TSC1 and TSC2 genes, causing the disinhibition of mechanistic target of rapamycin (mTOR) complex and leading to the dysregulation of cell metabolism, proliferation, and growth and ultimately the formation of benign tumours in multiple organ systems.